• 제목/요약/키워드: Vascular Remodeling

검색결과 68건 처리시간 0.029초

Long-Term Outcomes of Modified Cone Reconstruction for Ebstein's Anomaly in Pediatric Patients in a Single Center

  • Ilkun Park;Tae-Gook Jun;Ji-Hyuk Yang;I-Seok Kang;June Huh;Jinyoung Song;Ok Jeong Lee
    • Korean Circulation Journal
    • /
    • 제54권2호
    • /
    • pp.78-90
    • /
    • 2024
  • Background and Objective: We aimed to investigate long-term clinical and echocardiographic outcomes, including tricuspid valve durability, annular growth, and left ventricular reverse remodeling, after modified cone reconstruction in patients with Ebstein's anomaly. Methods: This was a retrospective analysis of all pediatric patients who underwent modified cone reconstruction for Ebstein's anomaly at a single tertiary center between January 2005 and June 2021. Results: A total of 14 pediatric patients underwent modified cone reconstruction for Ebstein's anomaly; the median age was 5.8 years (range, 0.01-16.6). There were three patients (21.4%) with Carpentier type B, ten patients with Carpentier type C (71.4%), and one patient with Carpentier type D (7.1%). There was no early or late mortality, arrhythmia, or readmission for heart failure at a 10-year follow-up. There were no cases of more than mild tricuspid stenosis or more than moderate tricuspid regurgitation during the study period, except for one patient with severe tricuspid regurgitation who underwent reoperation. The z value for tricuspid valve annular size significantly decreased immediately after the operation (2.46 vs. -1.15, p<0.001). However, from 1 year to 7 years after surgery, the z values were maintained between -1 and +1. Left ventricular end-systolic volume, end-diastolic volume, and stroke volume increased after surgery and remained elevated until seven years postoperatively. Conclusions: Ebstein's anomaly in children can be repaired by modified cone reconstruction with low mortality and morbidity, good tricuspid valve durability, and annular growth relative to somatic growth.

Therapeutic implications of microRNAs in pulmonary arterial hypertension

  • Lee, Aram;McLean, Danielle;Choi, Jihea;Kang, Hyesoo;Chang, Woochul;Kim, Jongmin
    • BMB Reports
    • /
    • 제47권6호
    • /
    • pp.311-317
    • /
    • 2014
  • microRNAs (miRNAs) are a class of small, non-coding RNAs that play critical posttranscriptional regulatory roles typically through targeting of the 3'-untranslated region of messenger RNA (mRNA). Mature miRNAs are known to be involved in global cellular processes, such as differentiation, proliferation, apoptosis, and organogenesis, due to their capacity to target multiple mRNAs. Thus, imbalances in the expression and/or activity of miRNAs are involved in the pathogenesis of numerous diseases, including pulmonary arterial hypertension (PAH). PAH is a progressive disease characterized by vascular remodeling due to excessive proliferation of pulmonary artery endothelial cells (PAECs) and pulmonary artery smooth muscle cells (PASMCs). Recently, studies have evaluated the roles of miRNAs involved in the pathogenesis of PAH in these pulmonary vascular cells. This review provides an overview of recent discoveries on the role of miRNAs in the pathogenesis of PAH and discusses the potential for miRNAs as therapeutic targets and biomarkers of PAH.

Combined Treatment of Stromal Vascular Fraction and Ablative Fractional CO2 Laser for Hypertrophic Foot Scar

  • Kim, Dong Gyu;Park, Eun Soo;Kim, Seok Hwan
    • Medical Lasers
    • /
    • 제8권2호
    • /
    • pp.90-93
    • /
    • 2019
  • The treatment of keloid and hypertrophic scars (HTSs) remains one of the most difficult challenges, with a high recurrence rate regardless of the method of treatment. The latest trend in scar management is a combined approach using multiple modalities that are individualized to the patient and that would provide successful results for keloid and HTSs. There are previous reports that stromal vascular fraction (SVF) is effective for scar remodeling. Based on these reports, we introduced the concept of a combination treatment using SVF injection and fractional ablative CO2 laser. In this report, we present a 21-year-old woman who was involved in a car accident. A defect on her foot was covered with a skin graft, but the scars became elevated, which turned out to be HTSs. She was treated with a fractional ablative CO2 laser for five sessions. A month later, SVF injection and fractional ablative CO2 laser were conducted simultaneously. The result of a year's follow-up showed a flattened scar with resolution of pigment deposition. In conclusion, the combination treatment for HTSs with SVF injection and ablative fractional CO2 laser is one of the modalities to achieve an excellent outcome for treating HTS.

전임상 혈관분석을 위한 초분광 이미징 시스템의 활용 (Application of Hyperspectral Imaging System to Analyze Vascular Alteration for Preclinical Models)

  • 최세운;우영운
    • 한국컴퓨터정보학회논문지
    • /
    • 제20권4호
    • /
    • pp.69-76
    • /
    • 2015
  • 본 논문에서는 초분광 이미징시스템을 이용하여 획득된 헤모글로빈 포화이미지와 다양한 이미지프로세싱을 통해 얻어진 실시간 혈관 변화과정을 마이크로미터/밀리초 부터 밀리미터/시간에 이르는 시공간 해상도로 제공하여, 다양한 질병에 기인한 혈관의 생성 및 변화 등과 같은 고유한 생리적 특성뿐만 아니라 혈관간의 산소이동, 혈관질환의 치료효과의 검증 등 다목적 영상장비로의 개발이 가능하다. 이는 질병으로 인한 혈관의 변이과정을 관찰하기 위해 최근 다양한 임상 및 전임상 영상장비들이 개발되고 있으나 높은 개발비용과 환자들이 감수해야하는 위험부담에 비해 상대적으로 낮은 해상도와 제한된 만족도를 제공한다 한계점을 극복할 수 있다. 새로운 혈관의 생성 및 기존의 모세혈관 변화는 암 전이 및 발전과정 뿐만 아니라 다양한 질병의 종류에 따라 다른 특성을 보이며 이를 통한 생리학적 분석이 가능하므로 혈관의 연구를 통한 질병종류 및 유무의 판단은 진단 과정의 핵심 요소이며 새로운 치료법의 효과를 평가할 수 있는 중요한 근거가 될 것으로 기대한다.

Vessel Remodeling after Intima-to-Intima Contact Anastomosis

  • Yeo, Hyeonjung;Kim, Hyodong;Son, Daegu;Hong, Changbae;Kwon, Sun Young
    • Archives of Plastic Surgery
    • /
    • 제44권2호
    • /
    • pp.95-100
    • /
    • 2017
  • Background Intima-to-intima microanastomotic vascular remodeling was explored, utilizing a polylactide-caprolactone absorbable vein coupler model (PAVCM), which was designed to simulate a non-absorbable counterpart system with the sole exception of being absorbable. Methods Six New Zealand white rabbits were used. After transection of the jugular vein, 2 PAVCMs were placed, 1 at each transected end. The stumps were slipped through the PAVCMs, and the venous wall was everted $90^{\circ}$ to achieve intima-to-intima contact. Reanastomosis of the transected jugular vein was performed bilaterally in 3 rabbits. In the other 3 rabbits, the jugular vein (20 mm) harvested from one side was interpositionally grafted to the jugular vein on the opposite side to ease the anastomotic tension. Patency testing, ultrasonography, and histologic assessments were conducted postoperatively at weeks 2, 4, 12, 16, 22, and 26. Results All anastomotic sites were patent, without stenosis, occlusion, or dilatation. In the histologic sections, immature endothelial regeneration was observed at week 2, which was completed by week 4. Regeneration of the tunica media was noted at week 12. Between week 22 and week 26, the tunica media fully regenerated and the coupler dissipated entirely. Conclusions Despite the absence of a coupler to act as an anastomotic buttress, the structure and function of all the vessels appeared normal, even histologically. These outcomes are true milestones in the development of an absorbable vein coupler.

Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor

  • Cha, Seung Ah;Park, Byung Mun;Kim, Suhn Hee
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제22권4호
    • /
    • pp.447-456
    • /
    • 2018
  • Angiotensin-(1-9) [Ang-(1-9)], generated from Ang I by Ang II converting enzyme 2, has been reported to have protective effects on cardiac and vascular remodeling. However, there is no report about the effect of Ang-(1-9) on pulmonary hypertension. The aim of the present study is to investigate whether Ang-(1-9) improves pulmonary vascular remodeling in monocrotaline (MCT)-induced pulmonary hypertensive rats. Sprague-Dawley rats received Ang-(1-9) ($576{\mu}g/kg/day$) or saline via osmotic mini-pumps for 3 weeks. Three days after implantation of osmotic mini-pumps, 50 mg/kg MCT or vehicle were subcutaneously injected. MCT caused increases in right ventricular weight and systolic pressure, which were reduced by co-administration of Ang-(1-9). Ang-(1-9) also attenuated endothelial damage and medial hypertrophy of pulmonary arterioles as well as pulmonary fibrosis induced by MCT. The protective effects of Ang-(1-9) against pulmonary hypertension were inhibited by Ang type 2 receptor ($AT_2R$) blocker, but not by Mas receptor blocker. Additionally, the levels of LDH and inflammatory cytokines, such as $TNF-{\alpha}$, MCP-1, $IL-1{\beta}$, and IL-6, in plasma were lower in Ang-(1-9) co-treated MCT group than in vehicle-treated MCT group. Changes in expressions of apoptosis-related proteins such as Bax, Bcl2, Caspase-3 and -9 in the lung tissue of MCT rats were attenuated by the treatment with Ang-(1-9). These results indicate that Ang-(1-9) improves MCT-induced pulmonary hypertension by decreasing apoptosis and inflammatory reaction via $AT_2R$.

기관지천식환자에서 기도내 혈관분포정도(vascularity) 및 다른 기도 재구성 소견과의 연관성 (Relationship Between Vascularity and Other Remodeling Parameters in Asthmatic Airway)

  • 김승준;이숙영;김명숙;노대근;권순석;김영균;김관형;문화식;송정섭;박성학
    • Tuberculosis and Respiratory Diseases
    • /
    • 제54권2호
    • /
    • pp.191-198
    • /
    • 2003
  • 연구배경 : 기관지천식에서 기도 재구성과 관련되는 병리학적 소견은 다양하다. 본 연구의 목적은 기관지천식 환자의 기도내 혈관분포정도 및 다른 기도 재구성 소견과의 관련성을 일아보는데 있다. 방 법 : 기관지천식환자(n=34)와 대조군(n=6)을 대상으로 기관지점막조직생검을 시행하였다. HE 염색으로 기저막 및 기저막하부의 두께를, type IV collagen 면역염색을 하여 혈관분포정도(점막하 단위면적당 혈관의 수와 혈관면적)를 image analyzer를 이용 하여 측정하였다. 결 과 : 1) 기관지천식환자에서 대조군에 비해 기저막 두께 ($6.92{\pm}2.01{\mu}m$ vs $9.67{\pm}2.84{\mu}m$, p<0.05) 및 기저막하부의 두께 ($44.49{\pm}31.92{\mu}m$ vs $121.22{\pm}72.79{\mu}m$, p<0.05) 가 유의하게 높았다. 2) 기관지천식환자에서 대조군에 비해 점막하 단위면적당 혈관면적은 유의하게 높았으며 ($4.51{\pm}2.13%$ vs $10.32{\pm}6.08%$, p<0.05) 점막하 단위면적당 혈관수는 높은 경향을 보였으나 통계적인 유의성은 없었다. 3) 기관지천식환자에서 점막하 단위면적당 혈관면적 및 혈관수는 기저막 두께, 기저막하부의 두께, 기관지천식의 중증도, $FEV_1$, $PC_{20}$ 등과 유의한 상관관계가 없었다. 결 론 : 본 연구결과 혈관분포정도가 기관지천식환자의 기도 재구성에 중요한 요소임을 확인할 수 있었으나 다른 기도 재구성의 요소들과는 직접적인 관련성은 없었다. 따라서 각각의 기도 재구성의 요소들은 서로 다른 임상적인 의의를 가칠 것으로 사료되며 이러한 요소들에 대한 추후 연구가 필요할 것으로 생각된다.

급성 천식환자에서 Vascular Endothelial Growth Factor와 Matrix Metalloproteinase-9 (Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 in Acute Asthma)

  • 박강서;진흥용;최유진;이흥범;이양근;이용철
    • Tuberculosis and Respiratory Diseases
    • /
    • 제51권6호
    • /
    • pp.530-539
    • /
    • 2001
  • 연구배경 : 기관지 천식은 기도의 재구성과 관련된 기도의 염증성 질환이다. Vascular endothelial growth factor(VEGF) 는 혈관생성과 염증반응에 관여하는 강력하고 다양한 기능의 사이토카인이며 Matrix metalloproteinase-9(MMP-9)은 기관지 천식에서 기도의 재구성을 일으키는 주요 단백분해 효소이다. 그러나, 아직 급성 기관지 천식에서 VEGF의 역할 및 VEGF와 MMP-9의 관련성등에 관한 보고는 거의 없다. 저자들은 급성 기관지 천식에서 VEGF가 기관지 염증반응에 관여하는지를 조사하였고 또한 객담내 VEGF 발현 정도와 MMP-9의 관련성도 같이 알아보고자 하였다. 방 법 : 저자들은 안정상태 및 급성천식상태 환자에서 객담내 VEGF와 MMP-9의 양을 효소 면역측정과 zymography 분석으로 측정하였고 또한 기관지 천식의 자발 발작시에도 측정하였다. 결 과 : 기관지 천식 환자군에서 안정상태의 천식환자군이나 건강 대조군보다 객담내 VEGF 양이 유의있게 높음을 알 수 있었고 또한 천식 발작시에는 안정시보다 더 유의있게 높았으며 천식치료후 점차 감소하였다. 급성 천식 환자들에서 객담내 VEGF농도는 호중구및 호산구들 수와 의의있게 관련이 있었고 또한 객담내 VEGF와 MMP-9의 농도사이에 유의있는 상관관계가 있음을 알 수 있었다. 결 론 : 급성 기관지 천식 환자에서 VEGF의 과도발현은 기도 염증반응과 관련이 있으며 또한 MMP-9과도 밀접한 연관성이 관련성이 있는 것으로 사료된다.

  • PDF

MG-63 세포주에서 Vascular Endothelial Growth Factor (VEGF) mRNA 발현에 대한 Insulin-like Growth Factor I (IGF-I)의 효과에 대한 연구 (THE EFFECTS OF INSULIN-LIKE GROWTH FACTOR I (IGF-I) ON EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) MRNA IN MG-63 OSTEOBLASTLIKE CELLS)

  • 서제덕;명훈;강나라;정필훈
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제31권5호
    • /
    • pp.363-369
    • /
    • 2005
  • Purpose: To determine the role of Insulin-like Growth Factor-I (IGF-I) in the regulation of Vascular Endothelial Growth Factor (VEGF) expression in MG-63 cells and then to find the mechanism b which this regulation occurs. Materials and methods: MG-63 cells were grown to confluence in 60-mm dishes. To determine the effects of IGF-I on expression of VEGF mRNA according to time and concentration, the cells were treated with 10 nM IGF-I, following isolation of total RNA and Northern blot analysis after 1, 2, 4, 8, 12, 24 hours and after 2 hours of treatment with 0.5, 2, 10, 25, 50 nM IGF-I respectively, isolation of total RNA and Northern blot analysis were followed. To determine the mechanism of action of IGF-I, inhibitors such as hydroxyurea $(76.1\;{\mu}g/ml)$, actinomycin D $(2.5\;{\mu}g/ml)$, cycloheximide $(10\;{\mu}g/ml)$ were added 1 hour after treatment of 10 nM IGF-I. Results: 1. the expression of VEGF mRNA was increased with treatment of IGF-I. 2. The expression of VEGF mRNA was increased according to time-and concentration dependent manner of IGF-I. 3. The effect of IGF-I was decreased by hydroxyuera, actinomycin D, but not by cycloheximide. Conclusion: IGF-I regulate the expression of VEGF mRNA in the level of DNA synthesis and transcription. These results could suggest that IGF-I plays an important role in angiogenesis in the process of new bone formation and remodeling.

Impact of Pulmonary Arterial Elastance on Right Ventricular Mechanics and Exercise Capacity in Repaired Tetralogy of Fallot

  • Soo-Jin Kim;Mei Hua Li;Chung Il Noh;Seong-Ho Kim;Chang-Ha Lee;Ja-Kyoung Yoon
    • Korean Circulation Journal
    • /
    • 제53권6호
    • /
    • pp.406-417
    • /
    • 2023
  • Background and Objectives: Pathophysiological changes of right ventricle (RV) after repair of tetralogy of Fallot (TOF) are coupled with a highly compliant low-pressure pulmonary artery (PA) system. This study aimed to determine whether pulmonary vascular function was associated with RV parameters and exercise capacity, and its impact on RV remodeling after pulmonary valve replacement. Methods: In a total of 48 patients over 18 years of age with repaired TOF, pulmonary arterial elastance (Ea), RV volume data, and RV-PA coupling ratio were calculated and analyzed in relation to exercise capacity. Results: Patients with a low Ea showed a more severe pulmonary regurgitation volume index, greater RV end-diastolic volume index, and greater effective RV stroke volume (p=0.039, p=0.013, and p=0.011, respectively). Patients with a high Ea had lower exercise capacity than those with a low Ea (peak oxygen consumption [peak VO2] rate: 25.8±7.7 vs. 34.3±5.5 mL/kg/min, respectively, p=0.003), while peak VO2 was inversely correlated with Ea and mean PA pressure (p=0.004 and p=0.004, respectively). In the univariate analysis, a higher preoperative RV end-diastolic volume index and RV end-systolic volume index, left ventricular end-systolic volume index, and higher RV-PA coupling ratio were risk factors for suboptimal outcomes. Preoperative RV volume and RV-PA coupling ratio reflecting the adaptive PA system response are important factors in optimal postoperative results. Conclusions: We found that PA vascular dysfunction, presenting as elevated Ea in TOF, may contribute to exercise intolerance. However, Ea was inversely correlated with pulmonary regurgitation (PR) severity, which may prevent PR, RV dilatation, and left ventricular dilatation in the absence of significant pulmonary stenosis.